SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced...
Plexigen developed a proprietary 3-D biochip designed to significantly enhance the capacity, efficiency, accuracy and automation of gene screening.
Plexigen
Cary, NC
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.